Sumitomo Mitsui Ds Asset Management Company, LTD Biogen Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $9.6 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 17,761 shares of BIIB stock, worth $2.43 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,761
Previous 19,702
9.85%
Holding current value
$2.43 Million
Previous $3.82 Million
28.88%
% of portfolio
0.03%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BIIB
# of Institutions
995Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.3 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.2 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.99 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.01 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$676 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...